X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (3) 3
aged (2) 2
female (2) 2
index medicus (2) 2
male (2) 2
[ sdv.mhep ] life sciences [q-bio]/human health and pathology (1) 1
[sdv.mhep]life sciences [q-bio]/human health and pathology (1) 1
adult (1) 1
adverse events (1) 1
alanine-trna ligase - antagonists & inhibitors (1) 1
alanine-trna ligase - immunology (1) 1
antiretroviral therapy (1) 1
antiviral agents (1) 1
antiviral agents - therapeutic use (1) 1
antiviral therapy (1) 1
autoantibodies - immunology (1) 1
b-cell lymphoma (1) 1
biological products industry (1) 1
biological response modifiers (1) 1
biology and life sciences (1) 1
cancer treatment (1) 1
cancers and neoplasms (1) 1
care and treatment (1) 1
chemotherapy (1) 1
clinical medicine (1) 1
clinical oncology (1) 1
clinical research design (1) 1
comparative analysis (1) 1
cryoglobulinemia vasculitis (1) 1
cyanosis - immunology (1) 1
cyanosis - pathology (1) 1
digestive system diseases (1) 1
drug development (1) 1
drug therapy (1) 1
drug therapy, combination (1) 1
enzyme-linked immunosorbent assay (1) 1
erythema multiforme - virology (1) 1
evaluation (1) 1
flaviviruses (1) 1
genotype (1) 1
health aspects (1) 1
hematologic cancers and related disorders (1) 1
hematology (1) 1
hemic and lymphatic diseases (1) 1
hepacivirus (1) 1
hepacivirus - genetics (1) 1
hepacivirus - isolation & purification (1) 1
hepatitis (1) 1
hepatitis c (1) 1
hepatitis c - complications (1) 1
hepatitis c - drug therapy (1) 1
hepatitis c - mortality (1) 1
hepatitis c - virology (1) 1
hepatitis c virus (1) 1
hepatitis viruses (1) 1
hepatitis-c (1) 1
hepatology (1) 1
herpes zoster - virology (1) 1
herpesvirus 3, human - isolation & purification (1) 1
human health and pathology (1) 1
immune system diseases (1) 1
immunology (1) 1
immunoproliferative diseases (1) 1
infection (1) 1
infections (1) 1
interferon (1) 1
interferon-alpha - therapeutic use (1) 1
internal medicine (1) 1
life sciences (1) 1
liver (1) 1
lymphocytes (1) 1
lymphocytes b (1) 1
lymphoma (1) 1
lymphoma, b-cell - complications (1) 1
lymphoma, b-cell - diagnosis (1) 1
lymphoma, b-cell, marginal zone - complications (1) 1
lymphoma, large b-cell, diffuse - complications (1) 1
lymphomas (1) 1
marginal zone lymphoma (1) 1
medical microbiology (1) 1
medicine (1) 1
medicine and health sciences (1) 1
medicine, general & internal (1) 1
microbial pathogens (1) 1
microbiology (1) 1
middle aged (1) 1
mixed cryoglobulinemia (1) 1
multidisciplinary sciences (1) 1
multivariate analysis (1) 1
non-hodgkin lymphoma (1) 1
non-hodgkin's lymphomas (1) 1
odds ratio (1) 1
oncology (1) 1
organisms (1) 1
pathogens (1) 1
pathology and laboratory medicine (1) 1
patients (1) 1
pharmaceutics (1) 1
polyethylene glycols - therapeutic use (1) 1
preventive medicine (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


PLoS ONE, ISSN 1932-6203, 10/2016, Volume 11, Issue 10, p. e0162965
Hepatitis C virus (HCV) infection is associated with lymphoproliferative disorders and B-cell non-Hodgkin lymphomas (B-NHLs). Evaluation of the efficacy and... 
VIRUS-INFECTION | THERAPY | MULTIDISCIPLINARY SCIENCES | MARGINAL ZONE LYMPHOMA | HEPATITIS-C | CRYOGLOBULINEMIA VASCULITIS | MIXED CRYOGLOBULINEMIA | Lymphoma, B-Cell - complications | Recombinant Proteins - therapeutic use | Multivariate Analysis | Hepatitis C - drug therapy | Humans | Lymphoma, B-Cell - diagnosis | Middle Aged | Hepacivirus - genetics | Male | RNA, Viral - blood | Polyethylene Glycols - therapeutic use | Lymphoma, B-Cell, Marginal Zone - complications | Female | Hepatitis C - complications | RNA, Viral - metabolism | Drug Therapy, Combination | Odds Ratio | Protease Inhibitors - therapeutic use | Hepacivirus - isolation & purification | Enzyme-Linked Immunosorbent Assay | Antiviral Agents - therapeutic use | Ribavirin - therapeutic use | Interferon-alpha - therapeutic use | Proportional Hazards Models | Genotype | Lymphoma, Large B-Cell, Diffuse - complications | Survival Rate | Treatment Outcome | Hepatitis C - mortality | Hepatitis C - virology | Aged | Surveys | Infection | Care and treatment | Protease inhibitors | Proteases | Biological products industry | Interferon | Non-Hodgkin's lymphomas | Biological response modifiers | Comparative analysis | Hepatitis C virus | Health aspects | Therapy | Liver | Viruses | Infections | Multivariate analysis | Drug development | Ribavirin | Hepatitis | α-Interferon | Lymphocytes | Hepatology | Safety | Public health | Evaluation | Antiviral agents | Internal medicine | Hematology | Immunoproliferative diseases | Proteinase inhibitors | Patients | Lymphoma | Medicine | Studies | Chemotherapy | Lymphocytes B | Lymphomas | Hepatitis C | B-cell lymphoma | Life Sciences | Human health and pathology
Journal Article
Presse Medicale, ISSN 0755-4982, 10/2014, Volume 43, Issue 10, pp. 1149 - 1150
Journal Article
La Presse Medicale, ISSN 0755-4982, 10/2014, Volume 43, Issue 10, pp. 1149 - 1150
Journal Article
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.